Kim Jae Yun, Kim Soo Nyoung, Park Chulmin, Lim Ho Young, Kim Jae Hun
Department of Anesthesiology and Pain Medicine, Konkuk University School of Medicine, Seoul, Korea.
Department of Obstetrics and Gynecology, Konkuk University School of Medicine, Seoul, Korea.
Korean J Pain. 2019 Jan;32(1):39-46. doi: 10.3344/kjp.2019.32.1.39. Epub 2019 Jan 2.
Lumbosacral transforaminal epidural injection (TFEI) is an effective treatment for spinal disease. However, TFEI may have several types of complications, some of which can be attributed to intravascular injection. We reviewed studies to compare the intravascular injection rate among different needle types.
We searched the literature for articles on the intravascular injection rate among different needle types used in TFEI. The search was performed using PubMed, MEDLINE, the Cochrane Library, EMBASE, and Web of Science.
A total of six studies comprising 2359 patients were identified. Compared with the Quincke needle, the Whitacre needle reduced the intravascular injection rate (OR = 0.57, 95% CI = [0.44-0.73], < 0.001). However, compared with the Quincke needle, the Chiba needle did not reduce the intravascular injection rate (OR = 0.80, 95% CI = [0.44-1.45], = 0.46). In one study, the intravascular injection rate using a blunt-tip needle was lower than that using a sharp needle. In another study, the Whitacre and the blunt-tip needle have similar intravascular injection rates, while, the catheter-extension needle showed a reduced intravascular injection rate.
This meta-analysis showed that the Whitacre needle reduced the intravascular injection rate as compared with the Quincke needle, but failed to establish that the Chiba needle can decrease the intravascular injection rate in TFEI. Moreover, the blunt-tip needle can reduce the intravascular injection rate compared with the Quincke needle, and the catheter-extension needle can reduce the intravascular injection rate compared with the Whitacre and the blunt-tip needle.
腰骶部经椎间孔硬膜外注射(TFEI)是一种治疗脊柱疾病的有效方法。然而,TFEI可能会出现多种并发症,其中一些可归因于血管内注射。我们回顾了相关研究,以比较不同类型针头的血管内注射率。
我们在文献中搜索关于TFEI中使用的不同类型针头的血管内注射率的文章。检索使用了PubMed、MEDLINE、Cochrane图书馆、EMBASE和Web of Science。
共纳入6项研究,涉及2359例患者。与Quincke针相比,Whitacre针降低了血管内注射率(OR = 0.57,95%CI = [0.44 - 0.73],P < 0.001)。然而,与Quincke针相比,Chiba针并未降低血管内注射率(OR = 0.80,95%CI = [0.44 - 1.45],P = 0.46)。在一项研究中,使用钝头针的血管内注射率低于使用尖头针的情况。在另一项研究中,Whitacre针和钝头针的血管内注射率相似,而导管延长针的血管内注射率降低。
这项荟萃分析表明,与Quincke针相比,Whitacre针降低了血管内注射率,但未能证实Chiba针可降低TFEI中的血管内注射率。此外,与Quincke针相比,钝头针可降低血管内注射率,与Whitacre针和钝头针相比,导管延长针可降低血管内注射率。